Safiglipron
A Trial of HRS-7535 Tablets in Subjects With Overweight or Obesity
Shandong Suncadia Medicine Co · Phase 3 · Completed · Enrollment 556
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| HRS-7535 Group | n/r | n/r | n/r | n/r |
| HRS-7535 Placebo Group | n/r | n/r | n/r | n/r |
Not shown
- HRS-7535 Group: endpoint not reported
- HRS-7535 Placebo Group: endpoint not reported